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Protection of human health against disease and
injury caused by toxic chemicals in the envi-
ronment is the ultimate goal of risk assessment
and risk management. Historically, risk assess-
ment focused on adult exposures and toxicities
and gave little consideration to vulnerable life
stages such as fetal development and early
childhood. An emphasis on adult cancer risk
and the evolution of methodologies for esti-
mating cancer risks that are different from the
methods used to assess other health effects
tended to further diminish the importance for
risk assessment of children’s exposures and
outcomes. In addition, the use of default fac-
tors based on the healthy young adult did not
account adequately for the unique exposures
and sensitivities of fetuses, infants, and chil-
dren (Landrigan and Carlson 1995).
In the past decade, stimulated especially
by the 1993 National Research Council
(NRC) report on Pesticides in the Diets of
Infants and Children [NAS (National
Academy of Sciences) 1993], recognition has
grown that children are a group within the
population who have unique exposures and
special vulnerabilities to environmental toxi-
cants. It is now understood that children
require an approach to risk assessment that
considers their particular characteristics. The
present report, developed by the International
Life Sciences Institute (ILSI) with support
from the U.S. Environmental Protection
Agency (U.S. EPA), is intended to consider
the elements and structure of a child-protec-
tive approach to risk assessment.
The purpose of this article is to introduce
a series of reports from an ILSI Workshop on
Risk Assessment and Children’s Health held
in July 2001. This article begins the discus-
sion of child-protective risk assessment by
a) summarizing information on the vulnera-
bility of children to agents in the environ-
ment; b) presenting a rationale, based on
considerations of public health and preven-
tive medicine, for developing an approach to
risk assessment that considers the unique
exposures and special sensitivities of infants
and children; and c) highlighting elements of
great importance for a child-protective
approach to risk assessment.
The word “children” is used throughout
this paper to include all stages of develop-
ment (fetuses, infants, and children) from
conception to 21 years of age.
The Historical Development 
of Child-Protective Risk
Assessment
The National Research Council report on
Pesticides in the Diets of Infants and
Children. Publication in 1993 of the NRC
report on Pesticides in the Diets of Infants
and Children (NAS 1993) was critical in rais-
ing awareness of the importance for risk
assessment of children’s environmental
health. This report elevated concern on a
broad national level about children’s special
vulnerabilities to environmental agents. It
made clear that protection of the health of
vulnerable populations would require a new
approach to risk assessment.
The NRC report recommended an
approach to risk assessment that moved
beyond consideration of average exposures
based primarily on adult characteristics to one
that accounted for the heterogeneity of expo-
sures and for potential differential sensitivities
at various life stages, particularly during pre-
natal development, infancy, and childhood.
The NRC report built on guidelines that the
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Infants and children are not little adults. They are uniquely vulnerable to environmental toxicants.
To protect infants and children against toxicants, the National Research Council in 1993 called for
development of an approach to risk assessment that considers children’s unique patterns of expo-
sure and their special vulnerabilities to pesticides. Many aspects of that call were codiﬁed into fed-
eral law in the Food Quality Protection Act (FQPA) of 1996. This report highlights the central
elements needed for development of a child-protective approach to risk assessment: a) improved
quantitative assessment of children’s exposures at different life stages, from fetal life through adoles-
cence, including acute and chronic exposures, exposures via multiple routes, and exposures to mul-
tiple agents; b) development of new approaches to toxicity testing of chemicals that can detect
unanticipated and subtle outcomes and that evaluate experimental subjects over the entire life span
from early exposure to natural death to replicate the human experience; c) development of new tox-
icodynamic and toxicokinetic models that account for the unique physiologic characteristics of
infants and children; d) development of new approaches to assessment of outcomes, functional,
organ, cellular and molecular, over the entire life span; these measures need to be incorporated into
toxicity testing and into long-term prospective epidemiologic studies of children; and e) application
of uncertainty and safety factors in risk assessment that speciﬁcally consider children’s risks. Under
FQPA, children are presumed more vulnerable to pesticides than adults unless evidence exists to
the contrary. Uncertainty and safety factors that are protective of children must therefore be incor-
porated into risk assessment when data on developmental toxicity are lacking or when there is evi-
dence of developmental toxicity. The adequate protection of children against toxic agents in the
environment will require fundamental and far-reaching revisions of current approaches to toxicity
testing and risk assessment. Key words: children’s environmental health, developmental toxicology,
risk assessment, safety factors, toxicity testing. Environ Health Perspect 112:257–265 (2003).
doi:10.1289/ehp.6115 available via http://dx.doi.org/ [Online 25 November 2003]
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toxicity risk assessment in 1986 and revised in
1991 (U.S. EPA 1986, 1991). It also built on
other published documents such as the ILSI
report on Similarities and Differences
between Children and Adults: Implications
for Risk Assessment (Guzelian et al. 1992).
Infants and children were identified in
both the NRC and ILSI reports as groups
within the population who require special
consideration in risk assessment because of
their unique patterns of exposures to environ-
mental hazards and their special vulnerabili-
ties. The NRC report noted that “children are
not little adults.” It called for the develop-
ment of new risk assessment methods that
would incorporate better data on children’s
exposures to pesticides along with improved
information on the potentially harmful effects
of pesticides during fetal development,
infancy, and childhood (NAS 1993).
To “provide a more complete characteri-
zation of risk,” the NRC committee recom-
mended use of exposure distributions rather
than point estimates. It noted that levels of
exposure could differ by several orders of
magnitude between children and adults. The
NRC report recommended also that exposure
assessment methods be expanded to consider
exposures to multiple chemicals with multiple
routes of exposure (NAS 1993).
To enhance characterization of the sus-
ceptibility of children, the NRC committee
recommended the development of physiologi-
cally based pharmacokinetic models that
could describe the unique features of young,
developing humans. To assess the long-term
and delayed effects of early exposures, the
committee recommended that “it would be
desirable to develop bioassay protocols that
provide direct information on the relative
contribution of exposures at different ages to
lifetime risks.” The committee called for fur-
ther development of “appropriate toxicological
tests for perinatal and childhood toxicity” to
address issues not addressed in current testing
guideline protocols (NAS 1993).
The NRC committee concluded that “in
the absence of data to the contrary, there
should be a presumption of greater risk to
infants and children. To validate this pre-
sumption, the committee recommended that
“the sensitivity of mature and immature indi-
viduals should be studied systematically
to expand the current limited database as to
relative sensitivity.”
To provide enhanced protection to chil-
dren during vulnerable periods of early devel-
opment, the NRC committee recommended
that a child-protective safety factor of up to
10-fold be considered in risk assessment
“when there is evidence of developmental
toxicity and when data from toxicity testing
relative to children are incomplete.” The
committee noted that it had long been stan-
dard practice at the U.S. EPA and U.S. Food
and Drug Administration to divide the no-
observed-effect-level (NOEL) obtained in ani-
mal test results by an uncertainty factor of
100-fold in establishing a reference dose
(RfD) for toxic effects other than cancer or
heritable mutation. The committee noted
that this 100-fold factor comprises two sepa-
rate factors 10-fold each: one allows for
uncertainty in extrapolating data from ani-
mals to humans; the second accommodates
variation within the human population. The
committee acknowledged that “this latter
uncertainty factor generally provides adequate
protection for infants and children.”
Nevertheless, the committee expressed con-
cern that the standard 100-fold safety factor
may not always be sufficient to account for
unique susceptibilities at particularly sensitive
stages of early development. The committee
was also concerned about the great gaps that
currently exist in developmental toxicity testing
data for many chemicals. It was for these rea-
sons that the NRC committee recommended
consideration of a third child-protective safety
factor in risk assessment.
Food Quality Protection Act of 1996. After
publication of the NRC report, the concept
that children should be considered more vul-
nerable to pesticides than adults in the absence
of evidence to the contrary was adopted by the
U.S. Congress. In 1996, by unanimous vote of
both Houses of Congress, the concept was
incorporated into the Food Quality Protection
Act of 1996 (FQPA 1996), the principal fed-
eral statute governing the use of pesticides in
agriculture. Major provisions of this act are as
follows:
• Standards for pesticide residues in food
must be health based. They must be set at
levels that ensure a “reasonable certainty of
no harm.”
• Exposure and vulnerabilities of infants and
children must be specifically considered in
establishing pesticide residue standards.
• When insufficient data exist to assess the
special exposures and/or vulnerabilities of
infants and children, an additional 10-fold
safety factor must be considered in setting
standards.
• Consideration of the potential benefits of
pesticides must be limited.
• All pesticide standards must be reviewed
every 10 years.
• Endocrine effects of pesticides must be sys-
tematically evaluated in toxicity testing.
FQPA incorporates most of the recom-
mendations of the NRC report. It requires that
standards for agricultural pesticides be set at
levels sufﬁciently strict to protect the health of
infants and children. It directs the U.S. EPA to
use an additional 10-fold margin of safety in
assessing the risks to infants and children to
take into account the potential for prenatal and
postnatal toxicity, particularly when the toxi-
cology and exposure databases are judged to be
incomplete. The statute authorizes the U.S.
EPA to replace this default 10-fold FQPA
safety factor with a different factor only if,
based on reliable data, the resulting margin
would be adequate to protect infants and chil-
dren. The requirement for the FQPA safety
factor was intended by Congress to be a stimu-
lus to the generation of data on developmental
toxicology and on early life exposures.
Recently, the U.S. EPA published its ﬁnal
guidance on the application of the additional
FQPA safety factor in risk assessment (U.S.
EPA 2002a). The agency will apply the addi-
tional factor at the beginning of the risk
assessment process but recognizes that the
intent of the FQPA safety factor overlaps with
several uncertainty factors traditionally used
to account for data gaps and concerns in the
risk assessment process. These include default
10-fold factors to account for: a) the lack of a
no observable adverse effect level (NOAEL)
(lowest observable adverse effect level to
NOAEL factor); b) the lack of chronic expo-
sure data for setting the chronic RfDs and ref-
erence concentrations (RfCs) (subchronic to
chronic factor); and c) inadequacies or gaps in
the database considered minimal for setting
RfDs/RfCs (database factor). In most cases,
the U.S. EPA has expressed the opinion that
these factors will be sufﬁcient to account for
the concerns related to children’s health. If,
however, the adequacy and appropriateness of
the toxicity assessment or the exposure assess-
ment are judged by the U.S. EPA’s risk asses-
sors to be insufficient, a part or all of the
child-protective FQPA factor is applied to the
RfD. The resulting FQPA-adjusted RfD is
termed the population-adjusted dose.
According to a report issued by Consumers
Union in February 2000, the U.S. EPA had
applied one or more additional safety factors
for 104 of 273 (38%) pesticides evaluated
between August 1996 and March 2001. For
the organophosphorus insecticides, one of U.S.
EPA’s high priority categories for review, addi-
tional safety factors were applied for 26 of 49
substances (Consumers Union of the United
States Inc. 2001).
Children’s Unique Vulnerability
to Toxicants in the Environment
The detailed analysis of children’s exposures
to environmental chemicals undertaken by
the NRC established that children’s height-
ened vulnerability to chemicals arises from
four sources described below (NAS 1993).
Children have disproportionately heavy
exposures to many environmental agents.
Children drink more water, eat more food, and
breathe more air pound-for-pound of body
weight compared with adults. For example,
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seven times as much water, whereas children
ages 1 through 5 years eat 3 to 4 times more
food on a body-weight basis than the average
adult. The air intake of a resting infant is twice
that of an adult. The implication of these ﬁnd-
ings for health is that children will have sub-
stantially heavier exposures than adults to any
environmental contaminants present in water,
food, and air (NAS 1993). Two additional
characteristics of children magnify their expo-
sures: their hand-to-mouth behavior and their
play close to the ground.
Children’s metabolic pathways, especially in
fetal life and in the ﬁrst months after birth, are
immature. Children’s ability to metabolize,
detoxify, and excrete environmental agents is
different from that of adults. In some instances,
children are better able than adults to deal with
environmental agents (NAS 1993; Spielberg
1992) because they cannot make the active
metabolite required for toxicity. In other
instances, children are less able to deal with
toxic chemicals and thus are more vulnerable to
them (NAS 1993; Spielberg 1992). Differences
in metabolism exist also between prenatal and
postnatal life and may vary over the course of
pregnancy. An additional source of vulnerabil-
ity in fetuses and young children is that the
blood–brain barrier is not fully developed, and
therefore xenobiotics may be more easily able to
enter the central nervous system (Rodier 1995).
Developmental processes are easily dis-
rupted during rapid growth and development
before and after birth. Rapid growth and
development occur during embryonic and fetal
life as well as in the ﬁrst years after birth. In the
brain for example, billions of cells must form,
move to their assigned positions, and establish
precise connections with other cells (Rodier
1995). Development of the endocrine and
reproductive organs is guided by a complex
and precisely timed sequence of chemical mes-
sages. If cells in an infant’s brain are destroyed
by chemicals, if connections between neurons
fail to form, or if false signals are sent to the
developing reproductive organs by endocrine
disruptors (EDs), neurological or reproductive
dysfunction may result (Bellinger et al. 1987;
Needleman et al. 1990; Jacobson and Jacobson
1996). Because children have more future years
of life than most adults, they have more time
to develop chronic diseases that may be trig-
gered by early exposures. Many diseases caused
by toxic agents in the environment require
decades to develop.
Children have more years of future life and
thus more time to develop diseases initiated by
early exposures. Many of those diseases, includ-
ing cancer and neurodegenerative diseases, are
thought to arise through a series of changes
within cells that require many years to evolve
from initiation to actual manifestation of
illness. Exposures to environmental agents
early in life, including prenatal exposures,
appear more likely to produce chronic disease
than similar exposures encountered later
(Ekbom et al. 1997; Gray et al. 1991). Thus,
there are likely to be critical windows of expo-
sure, even for these chronic diseases, that need
to be further explored.
Risks at Different Ages
Children are exposed to toxic agents through
the air they breathe, the water they drink, the
foods they eat, the medications they consume,
and the wide variety of environments they
inhabit, including their homes, day care cen-
ters, schools, and motor vehicles. Children
have unique routes of exposure that have no
parallel among adults, and the routes of expo-
sure and the resulting risks to health differ in
different stages of childhood. Contact with
toxic agents can occur in utero through trans-
placental transfer of chemicals from mother to
fetus; it can occur via breast milk in nursing
infants; and it can occur in early childhood via
hand-to-mouth transfer of toxic chemicals.
Analysis of children’s varying patterns and
pathways of exposure to environmental agents
and the resulting health effects at various stages
of development is an essential prerequisite to
formulation of a child-protective approach to
risk assessment.
Early examples of unique vulnerability to
pharmaceuticals during pregnancy. In preg-
nancy, especially in the ﬁrst trimester, mater-
nal use of certain medications has been linked
to a number of adverse effects in humans.
The ﬁrst of these outcomes to be recognized
were anatomical birth defects. Examples of
these unique risks include the following:
• In 1961 a sudden increase in the frequency
of limb reduction defects, phocomelia in par-
ticular, in West Germany and Australia was
shown to have been caused by maternal pre-
natal use of the sedative-hypnotic thalido-
mide (Lenz 1962; McBride 1961; Taussig
1962). Removal of the drug from the market
led to a substantial decrease in the frequency
of limb reduction defects.
• In utero exposure to aminopterin, an
antagonist of folic acid, has been associated
with anencephaly, meningocele, hydro-
cephalus, and cleft lip and palate (Thiersch
1952; Warkany et al. 1959).
• In utero exposure to the anticonvulsant
diphenylhydantoin has been associated with
a broad spectrum of abnormalities, including
orofacial clefts, nail and digital hypoplasia,
growth abnormalities, and mental deﬁciency
(Fedrick 1973; Monson et al. 1973).
• In utero exposure to valproic acid, another
anticonvulsant, has been associated with
neural tube defects and heart, craniofacial,
and limb anomalies (Kallen et al. 1989).
• In utero exposure to the anticoagulant
coumadin has been associated with hypoplasia
of the nasal cartilage, chondrodysplasias, and
atrophy of the optic nerves (Warkany 1976).
• In utero exposure to isotretinoin (13-cis-
retinoic acid), an analog of vitamin A used to
treat cystic acne, is associated with a character-
istic pattern of malformations, including
abnormal ear development, a ﬂat nasal bridge,
mandibular hypoplasia, cleft palate, hydro-
cephalus, neural tube defects, and conotruncal
heart defects (Lammer et al. 1985).
• Administration of diethylstilbestrol (DES) to
pregnant women to prevent miscarriage has
been shown to cause various genital abnormal-
ities in their offspring (Bongiovanni et al.
1959; Gill et al. 2002) as well as the develop-
ment of adenocarcinoma of the vagina of their
daughters in their late teens and early twenties
(Herbst et al. 1971; O’Brien et al. 1979).
Many teratogenic agents were also found to
cause neurological and other functional disor-
ders in children that are not necessarily associ-
ated with gross structural alterations. For
example, isotretinoin causes profound mental
retardation in many children, and about half
those children do not have any major malfor-
mations (Adams and Lammer 1993, 1995).
DES causes a variety of reproductive prob-
lems in addition to vaginal adenocarcinoma,
including infertility and poor pregnancy out-
comes (Kaufman et al. 2000). Most recently,
exposures to thalidomide and valproic acid in
early pregnancy have been linked to autism
(Moore et al. 2000; Stromland et al. 1994).
Examples of unique vulnerabilities to
environmental agents. Heavy metals. Despite
a decline in exposures over the past two
decades (American Academy of Pediatrics
Committee on Environmental Health 1998;
Brody et al. 1994), resulting principally from
removal of lead from gasoline, lead exposure
continues to occur in utero and among chil-
dren of preschool age in the United States. A
national survey (conducted from October
1991 to September 1994) indicated that an
estimated 940,000 preschool children had
blood lead levels above the Centers for
Disease Control and Prevention (CDC) inter-
vention level of 10 µg/dL; nearly 275,000 had
blood lead levels greater than 15 µg/dL, and
nearly 85,000 had greater than twice the
CDC intervention level (20 µg/dL) (CDC
1997). Today, lead-based paint in older
homes is the most common source of lead
exposure in children (CDC 1997). Exposures
can occur through ingestion of paint chips or
dust from deteriorating surfaces, from chew-
ing on painted cribs, or through inhalation of
lead paint dust, as can occur during home ren-
ovation. Children exposed prenatally to blood
lead levels as low as 10 µg/dL, and possibly
even as low as 5 µg/dL (Lanphear et al. 2000),
may have delayed early mental development.
Further, chronic low-level lead exposure dur-
ing childhood may result in a decreased IQ,
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deficits, and persistent behavioral problems
(Bellinger et al. 1987; Needleman et al. 1990,
2002). The fact that toddlers are an age group
at high risk of lead poisoning is a direct con-
sequence of their unique hand-to-mouth
behavior, coupled with the fact that their
brains are still undergoing growth, develop-
ment, myelination, and differentiation.
Prenatal exposure to methyl mercury has
been shown to have adverse effects on neuro-
development. This is an age-specific, unique
risk that results from transplacental transfer of
mercury from maternal blood to the fetal
brain. Mercury deposited from the atmos-
phere into lakes, streams, and oceans can be
converted into organic mercury compounds
that accumulate in fish and biomagnify as
they move up the food chain to reach highest
levels in top predator ﬁsh species and marine
mammals. These compounds are lipid soluble
and are well absorbed from the gastrointesti-
nal tract (Clarkson 1972). Methyl mercury
crosses the placenta and is excreted in breast
milk. Consumption of ﬁsh with high levels of
methyl mercury by pregnant women in
Minamata Bay, Japan, in the 1950s was asso-
ciated with cerebral palsy in their offspring
(Harada 1968). When people in Iraq con-
sumed grain treated with a methyl mercury
fungicide between 1959 and 1972, thousands
were poisoned (Bakir et al. 1973). In both of
those episodes, mothers who were asympto-
matic or showed mild toxic effects gave birth
to infants who appeared normal at birth, but
in whom psychomotor retardation, blindness,
deafness, and seizures developed over time
(Amin-Zaki et al. 1979). For further assess-
ment of the susceptibility of the fetus and
infants to the neurotoxic effects of methyl
mercury, three longitudinal studies are being
undertaken to evaluate the long-term subclin-
ical effects among children whose mothers’
diets during pregnancy included large
amounts of ﬁsh or marine mammals contain-
ing methyl mercury (Crump et al. 1998;
Davidson et al. 1998; Grandjean et al. 1997).
A report from the NAS based on an analysis
of these three studies has concluded that low-
level exposures to methyl mercury in utero can
have adverse effects on neurobehavioral devel-
opment (NAS 2000). The U.S. EPA has
issued a new risk assessment for methyl mer-
cury, setting the chronic oral RfD at
0.01 µg/kg/day (U.S. EPA 2001). This RfD is
based principally on the finding of develop-
mental neuropsychological impairments in
children from the Faroe Island epidemiology
study and on supporting data from the New
Zealand study.
Environmental tobacco smoke. Environ-
mental tobacco smoke (ETS) is a complex
mixture of chemicals generated during the
burning and smoking of tobacco products.
Chemicals present in ETS include irritants
and systemic toxicants such as hydrogen
cyanide and sulfur dioxide (SO2), mutagens
and carcinogens such as benzo[a]pyrene,
formaldehyde, and 4 aminobiphenyl, and the
reproductive toxicants nicotine, cadmium, and
carbon monoxide (CO) (Jenkins et al. 1992).
Of children in the United States 11 years of
age and younger, 43% live in a home with at
least one person who smokes (Pirkle et al.
1996). Exposures of children to ETS produce
a range of effects, some of which are unique to
early life, and others that are analogous to the
effects produced by ETS in adults.
Prenatal exposure to ETS affects fetal
growth and is associated with a 20–40%
elevated risk of low birth weight or “small
for gestational age” [CEPA (California
Environmental Protection Agency) 1997;
Eskenazi et al. 1995; Haddow et al. 1988;
WHO 1999]. The primary effect observed,
reduction in mean low birth weight, is small
in magnitude (25–50 g). However, if the dis-
tribution of birth weight in a population of
babies is shifted downward by ETS exposure,
infants who are already compromised may be
pushed into higher risk categories. Because
low birth weight is associated with increased
infant morbidity and mortality, exposure to
ETS is likely to augment such burden.
Exposure to ETS during infancy has been
associated with an increased risk of sudden
infant death independent of low birth weight
or prematurity (Klonoff-Cohen et al. 1995;
Taylor and Sanderson 1995).
In children ETS exposure affects the
upper and the lower respiratory tract. Infants
and young children are at particular risk of
exposure to ETS because of the small diame-
ter of their airways and because pound-for-
pound they breathe more air than adults.
Infants exposed to ETS in their home envi-
ronment have a 1.5- to 3-fold increased risk
of lower respiratory infection compared with
unexposed children (McConnochie and
Roghmann 1986; Ogston et al. 1987; ). The
risk of lower respiratory infection associated
with ETS is highest among infants under
3 months of age (Wright et al. 1991).
Children whose parents smoke also are more
likely to develop middle ear effusion, as meas-
ured by tympanometry (Reed and Lutz 1988;
Strachan et al. 1989), and chronic respiratory
problems (cough, phlegm, or wheezing)
(Mannino 1996). Children exposed to ETS
are at elevated risk of developing asthma, and
those with asthma are more likely to experi-
ence more severe disease (Chilmonczyk et al.
1993; Martinez et al. 1992; Weitzman et al.
1990). Childhood exposure to ETS affects
lung growth and development, as measured
by small but significant decrements in pul-
monary function tests (Cullinan and Taylor
1994; Cunningham et al. 1994; Lebowitz
et al. 1992; Wang et al. 1994). Because early
lung development is important in terms of
future respiratory health, these results suggest
that ETS may have adverse long-term effects
on children’s respiratory health that warrant
further investigation through longitudinal
studies.
Air pollutants. Various indoor air pollu-
tants are associated with respiratory disorders
in children, and these pollutants include par-
ticles, gases, vapors, allergens, and molds
(Lambert and Samet 1996; Spengler 1991;
U.S. EPA 1994). In the home, common
sources of air pollutants other than tobacco
smoking include gas and wood stoves and fur-
nishings and construction materials that
release organic gases and vapors, some of
which contain formaldehyde. Combustion of
natural gas results in the emission of nitrogen
dioxide (NO2) and CO. Cooking or heating
with wood results in the emission of several
substances in the form of liquid (suspended
droplets), solids (suspended particles), and
gases such as NO2 and SO2 (Lambert and
Samet 1996). The aerosol mixture of very ﬁne
solid and liquid particles or “smoke” contains
particles in the inhalable range [i.e., < 10 µm
in aerodynamic diameter (PM10)]. Exposure
to CO disrupts oxygen transport and may
result in symptoms that mimic influenza,
including fatigue, headache, dizziness, nausea
and vomiting, cognitive impairment, and
tachycardia (Lambert and Samet 1996).
Exposure to high levels of NO2 and SO2 may
result in acute mucocutaneous irritation and
respiratory effects, and chronic exposure to
relatively lower levels has been linked to
asthma and respiratory irritation (Morrow
1984; Neas et al. 1991). Exposure to particles
in wood smoke may result in irritation and
inflammation of the respiratory tract, mani-
fested as rhinitis, cough, wheezing, and wors-
ening of asthma (Morris et al. 1990; Robin
et al. 1996). Whether adults exposed to simi-
lar levels of wood smoke have a different
probability of severe lower respiratory illnesses
is unclear.
Indoor environments also contain a num-
ber of aeroallergens that trigger asthma
episodes in children, including allergens of
house dust mites, cats, and cockroaches
(Cullinan and Taylor 1994). In urban
dwellings, house dust mite and cockroach
allergens are important in both onset and
worsening of asthma symptoms (Cullinan
and Taylor 1994). Cockroach allergens are
common in the homes of inner-city children
with asthma (Call et al. 1992; Rosenstreich
1997). Recent clinical and epidemiologic
studies indicate that exposure to molds or
dampness may increase the risk of respiratory
symptoms among children (Dales et al. 1991;
Delﬁno et al. 1997; Verhoeff et al. 1995). It is
unclear whether the increasing prevalence of
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asthma morbidity in children in recent years
is due to an increased prevalence of exposure
to aeroallergens, molds, or dampness, or to a
combination of those indoor factors with
changing patterns of ambient air pollution.
Ambient air pollution levels are also associ-
ated with asthma and other respiratory mor-
bidity in children. Daily ﬂuctuations in PM10
have been associated with increased emergency
room visits for childhood asthma (Rennick and
Jarman 1992; Schwartz et al. 1993), hospital
admissions for asthma (Montealegre et al.
1993), decrements in peak ﬂow rates in normal
children (Neas et al. 1995), increased respira-
tory symptoms (Forsberg et al. 1993), and
increased medication use in children with
asthma (Pope 1991). Ozone has been of partic-
ular concern, as it provokes airway inﬂamma-
tion at very low levels (Aris et al. 1993). In
addition, ozone increases airway reactivity
(Horstman et al. 1990; Kreit et al. 1989), and
there is evidence to suggest that ozone may
potentiate the effects of allergens (Molfino
et al. 1991). Ozone levels have been related to
increases in asthma admissions and emergency
room visits among children in Atlanta, Georgia
(White et al. 1994), New Jersey (Cody et al.
1992), and Mexico City (Romieu et al. 1995).
A study of the effect of increases in ambient
ozone levels on children and workers in sum-
mer day camp in New Jersey suggests that chil-
dren may be more sensitive than adults to
increases in ambient ozone levels (Cody et al.
1992). In this study, increases in ozone con-
centrations above 120 ppb were associated
with an increase in respiratory symptoms and a
decline in peak expiratory flow rate among
children but with no change in respiratory
symptoms or pulmonary function among
camp workers.
The potential impact of air pollution on
childhood asthma morbidity in a community
is exemplified by a report from CDC that
examined hospitalizations for asthma in the
Atlanta metropolitan area during the summer
of 1996 in the weeks before, during, and after
the summer Olympic Games. This analysis
found that the rate of asthma hospitalization
declined during the 2 weeks of the games,
when citizens of Atlanta heeded an advisory
from the mayor to improve air quality by not
driving and by using public transportation
instead. Emergency room visits for nonrespi-
ratory conditions in children remained con-
stant, indicating that diminished access to
emergency rooms did not account for the
decline in emergency room visits for respira-
tory problems. After the Games ended, motor
vehicle traffic increased, air quality deterio-
rated, and childhood asthma hospitalization
rates rebounded (Friedman et al. 2001).
Finally, ambient air pollutants, especially
ﬁne particulates, CO, and diesel exhaust, have
been linked in epidemiologic studies to low
birth weight, prematurity, and increased risk
of birth defects (Ashworth 1998; Bobak 2000;
Bobak et al. 2001; Dejmek et al. 1999; Gold
et al. 1999; Ha et al. 2001; Perera et al. 2003;
Ritz and Yu 1999; Ritz et al. 2000, 2002;
Wang et al. 1997; Wilhelm and Ritz 2003).
Diseases and Outcomes in
Children of Known or Suspected
Environmental Origin
Patterns of disease among children in industri-
ally developed nations today are quite different
from those of generations past (Haggerty and
Rothman 1975). Many of the traditional
infectious diseases have been controlled: small-
pox is eradicated, polio is nearly gone, measles
is under control, diphtheria and tetanus are
rarities, and cholera has virtually disappeared.
Although AIDS and tuberculosis remain very
much with us, the impact of the infectious dis-
eases upon childhood mortality is greatly
diminished. The expected life span of a baby
born in the United States today is more than
two decades longer than that of an infant born
at the beginning of the twentieth century
(Haggerty and Rothman 1975). Similar epi-
demiologic transitions from infectious to non-
infectious diseases are occurring at various
rates today in many nations around the world
as those countries strengthen public health
programs, control the classic infectious dis-
eases, and move toward industrial develop-
ment. In other countries, sadly, the increasing
incidence of HIV positivity and of AIDS
threatens to undo those gains.
Children today are at risk of disease caused
by environmental hazards not encountered by
previous generations. Over 85,000 synthetic
chemical compounds, most of which have
been developed since World War II, are now
registered for commercial use in the U.S.
EPA’s Toxic Substances Control Act inven-
tory. There are currently 2,800 chemicals pro-
duced in quantities of one million pounds or
more per year (Goldman and Koduru 2000).
These high-production-volume (HPV) chemi-
cals are those with the potential to be most
widely used in foods and consumer products
and to be most widely disseminated in the
environment. Fewer than half of these HPV
chemicals have been tested for their potential
toxicity to humans, and fewer still for their
toxicity to children (Goldman and Koduru
2000; NAS 1984). Thus, their potential haz-
ards to children’s health and development are
mostly unknown (Schaefer 1994).
Diseases of great importance to children in
America today that are thought, or at least sus-
pected, to be caused or aggravated by chemi-
cals in the environment include the following:
Asthma. A recent study by the National
Center for Health Statistics that surveyed data
on self-reports of asthma, physician’s office
visits for asthma, emergency room visits for
asthma, and hospitalizations for asthma
provides evidence for increases in prevalence of
asthma in the United States during the past
15 years, particularly among children (CDC
1995a). Estimates of the average rates of
asthma prevalence increased over time across
all age groups. Asthma mortality also increased.
Children experienced some of the higher rates
of morbidity as measured by self-reports, ofﬁce
visits, emergency department visits, and hospi-
talizations for asthma. These increases were
particularly evident in urban localities. In New
York and in other major cities, asthma has
become the leading cause of admission of chil-
dren to hospitals and the leading cause of
school absenteeism (CDC 1995b). The
increasing prevalence of asthma and the higher
asthma morbidity among children in the
United States, albeit still unexplained, suggest
that, compared with adults, children are more
likely to develop asthma and asthma exacerba-
tions and/or be exposed to chemical or other
factors that cause or trigger asthma episodes.
Childhood cancer. The reported incidence
of childhood cancer has increased substantially
in the United States in the past two decades
(Devesa et al. 1995). Although death rates are
down as a consequence of early detection and
vastly improved treatment, data from the
National Cancer Institute show that the
reported incidence of acute lymphoblastic
leukemia (ALL) increased by 27.4% from
1973 to 1990, from 2.8 cases per 100,000
children to 3.5 per 100,000. Since 1990, ALL
incidence has declined in boys but continues
to rise in girls (Robison et al. 1995). From
1973 to 1994, the incidence of brain cancer
increased by 39.6%, with nearly equal
increases in boys and girls (Schechter 1999).
Neurodevelopmental disorders. Neuro-
developmental disorders, including learning
disabilities, dyslexia, mental retardation, atten-
tion deficit disorder, and autism, are wide-
spread and affect 5–10% of the four million
babies born in the United States each year.
Some clinical investigators have reported that
prevalence is increasing, but existing data are
not of sufficient quality to either sustain or
refute that position (American Academy of
Pediatrics 2001). Causes are mostly unknown,
but in utero and early-life exposures to lead
(Bellinger et al. 1987; Needleman et al. 1990),
mercury (NAS 2000), polychlorinated
biphenyls (PCBs) (Jacobson and Jacobson
1996), certain pesticides (Campbell et al. 1997;
Eskenazi et al. 1999; Whitney et al. 1995;
Wiles and Campbell 1993), and other environ-
mental neurotoxicants are known or thought
to contribute to the burden of disorders (NAS
1992). A recent report from the NRC con-
cluded that 3% of developmental disabilities
are the direct consequence of neurotoxic envi-
ronmental exposures, and that another 25%
arise out of the interplay of environmentalfactors and individual genetic susceptibility
(environment was defined broadly in this
report and included diet, alcohol, tobacco and
other lifestyle factors, as well as toxic chemi-
cals) (NRC 2000).
Endocrine disruption. Endocrine disruptors
are chemicals that have the capacity to interfere
with the body’s hormonal signaling system
(Harrison 2001; Longnecker et al. 1997).
Effects of these chemicals, which have been
hypothesized to include cancer (Kogevinas et al.
1997), decreased fertility (Peterson et al. 1993),
birth defects of the reproductive organs
(Longnecker et al. 2002; Paulozzi et al. 1997),
altered sex ratios (Mocarelli et al. 2000), neu-
rodevelopmental impairment (Jacobson and
Jacobson 1996), thyroid dysfunction, and dia-
betes (Longnecker and Daniels 2001), have
been observed in vitro in cell systems
(Birnbaum 1994) and in vivo in experimental
animals exposed to speciﬁc chemicals in the lab-
oratory (Gray et al. 2000) as well as in wildlife
populations in several broadly contaminated
ecosystems such as the Great Lakes (Colborn
et al. 1996) and in Lake Apopka in Florida
(Guillette et al. 1994).
On the basis of animal studies, the embryo,
fetus, and neonate, and the child in the prepu-
bertal period appear to be at particularly high
risk of adverse consequences after exposure to
EDs (Selevan et al. 2000). Early exposures to
these compounds have the potential to alter
anatomic structures and may influence the
subsequent course of endocrine functioning
(Longnecker et al. 2002; Peterson et al. 1993),
neurological development (Jacobson and
Jacobson 1996), and sexual development over
the life span (Birnbaum 1994; Blanck et al.
2000a, 2000b; Colborn et al. 1996; Euling
and Kimmel 2001; Gray et al. 2000; Guillette
et al. 1994; Longnecker and Daniels 2001;
Selevan et al. 2000; Wu et al. 2003).
Evidence for the effects of EDs on human
health is less abundant than evidence for
effects in vitro and in wildlife, but data on
human developmental effects of EDs are
accumulating. These effects involve the repro-
ductive organs as well as the brain. The ﬁrst
report of an effect of an ED on human devel-
opment was the seminal observation by
Herbst (Herbst and Bern 1981) of eight cases
of clear cell adenocarcinoma (CCA) of the
vagina in young women who had been
exposed in utero to DES. Ultimately, more
than 300 cases of CCA were documented in
women exposed in utero to DES (NAS 1999)
Other examples of the human developmental
toxicity of the organochlorine EDs are
reduced intelligence and sperm abnormalities
in Taiwanese boys after prenatal exposure to
PCBs and furans (Guo et al. 2000); reduc-
tions in intelligence in U.S. and German chil-
dren after prenatal exposure to PCBs
(Jacobson and Jacobson 1996; Winneke
1995); alterations in gender-related play
behavior in Dutch children exposed pre-
natally to PCBs (Weisglas-Kuperus et al.
2000); altered sex ratio at birth in infants in
Italy and Russia after prenatal exposure to
dioxins (Mocarelli et al. 2000); and acceler-
ated onset of puberty in Michigan girls
exposed prenatally to polybrominated
biphenyls (Blanck et al. 2000b).
Through the FQPA, Congress has man-
dated more extensive screening of chemical
compounds to assess their potential for
endocrine disruption (FQPA 1996).
Critical Issues for Improved
Assessment of Environmental
Health Risks to Children
Protection of children’s health against the
adverse effects of exposures to toxic environ-
mental agents will require an approach to risk
assessment that moves beyond consideration
of average levels of exposure and risk and
beyond consideration of only the 60–70 kg
average adult (U.S. EPA 1999, 2002b). This
new approach must account for children’s
exposures to multiple chemicals and must be
based on better developmental toxicity data
than currently exist for most chemicals. To
account for the unique exposures and special
vulnerabilities of infants and children (NAS
1993), this new child-protective approach to
risk assessment will need to include the
elements described below.
Improved exposure assessment. Additional
data are needed on children’s patterns and
levels of exposures to chemicals in the envi-
ronment. Because exposures vary by age, this
information will need to be collected for dif-
ferent age groups, from the nursing infant
through the adolescent.
Accurate and frequently updated informa-
tion is needed on children’s diets at different
ages and on the concentrations of xenobiotics
in those diets. Surveys should regularly be
conducted also of levels of chemical contami-
nants in breast milk. Better data are needed
on the extent of exposure that results from
children’s unique mouthing behaviors.
All sources of exposure need to be con-
sidered in evaluating the potential risks of envi-
ronmental chemicals to infants and children
(NAS 1993). Models need to be developed
that can account for children’s simultaneous
exposures to multiple chemicals of differing
potency via multiple routes of exposure. These
models need to be able to assess the cumulative
effects of chemicals that may have either syner-
gistic or antagonistic actions. The U.S. EPA’s
recent work in assessing exposures to multiple
organophosphate pesticides is a useful ﬁrst step
in this direction.
Exposure estimates need to be con-
structed differently, depending on whether
acute or chronic effects are of concern. The
incorporation of biomarkers into data collec-
tion may be useful.
Most important, it is essential to examine
the full distribution of children’s exposures to
chemicals in the environment. Point estimates
of average exposure are no longer sufficient.
The actual distribution of the range of chil-
dren’s exposures across the population needs
to be determined through field studies.
Appropriate mathematical models must be
constructed, such as Monte Carlo models,
that can permit the combining of various data
sets and thus permit examination of full expo-
sure distributions (NAS 1992). Of special
concern are children whose exposures fall into
the top 10, 5, or 1% of the population.
Enhanced toxicity testing. New, more sen-
sitive approaches to chemical toxicity testing
are needed that can reliably detect the unantic-
ipated developmental consequences of expo-
sures during critical windows of prenatal and
postnatal vulnerability (Selevan et al. 2000).
These new models of developmental toxicity
testing need to generate data on organ systems
that have not been adequately addressed in the
past, for example, the nervous, immune, respi-
ratory reproductive, cardiovascular, and
endocrine systems.
A shortcoming with much current toxicity
testing is that test chemicals are administered
to experimental animals in adolescence, and
the animals are subsequently sacrificed at a
point in life that corresponds roughly to a
human age of 60–65 years (Mehlman et al.
2002). Thus, both the unique impacts of early
exposures and any late effects of early expo-
sures are not captured (U.S. EPA 2002b),
including cancer, heart disease, neurological
disorders, or diabetes. To improve current tox-
icity testing, for certain classes of chemicals
investigators may need to undertake studies in
which chemicals are administered to experi-
mental animals either in utero or shortly after
birth and the subjects then followed over their
entire natural life span. For other classes of
compounds, it may be necessary to expose ani-
mals throughout the life span. The approach
should attempt to replicate the human experi-
ence and may enhance detection of delayed
effects (NAS 1992).
Too much reliance on anatomical observa-
tion of readily observed anomalies as well as
insufﬁcient testing of the functioning of organ
systems have been features of much traditional
toxicity testing. To improve the situation,
enhanced functional tests of neurobehavioral,
immune, endocrine, and reproductive toxicity
will be of great importance (U.S. EPA 1986,
1991, 2002b). These functional assessments
need to be applied on a more routine basis,
especially when data from other studies, for
example, adult target organ toxicity, or multi-
generation studies, raise concerns about possible
developmental effects.
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models. The physiological and biochemical
characteristics of children that influence
metabolism and disposition of chemicals at
different stages of development need to be con-
sidered in risk assessment. Physiological para-
meters, such as tissue growth rates, and
biochemical parameters, such as enzyme induc-
tion, may differentially affect the responses of
infants and children to environmental chemi-
cals at different developmental stages (Cresteil
1998; Ginsberg et al. 2002). Physiologically
based pharmacokinetic models can be used to
estimate the dose of toxic metabolites reaching
target tissues at different developmental stages
(O’Flaherty 1997; Welsch 1995).
A mechanistically based approach to
hazard assessment. The pathogenic mechanisms
of environmentally induced disease in children
need to be elucidated at functional, organ, cel-
lular, and molecular levels (Birnbaum 1994;
Campbell et al. 1997; Whitney et al. 1995).
These assessments could be undertaken in con-
junction with toxicity testing of chemicals and
also in the context of epidemiologic studies.
Clinical and epidemiologic studies are of
proven value for studying etiologic associations
between environmental exposures and pediatric
disease (Bellinger et al. 1987; Jacobson and
Jacobson 1996; Needleman et al. 1990). A
strong argument can be made for the need to
establish a major multiyear prospective epi-
demiological study of children’s health, the
National Children’s Study, as a means of iden-
tifying and characterizing the consequences of
multiple, early, low-level exposures, as called for
in the Children’s Health Act 2000 (Berkowitz
et al. 2001; The National Children’s Study
Interagency Coordinating Committee 2003).
The advantages of such a study would be its
great statistical power, coupled with the ability
to examine prospectively the impact of a variety
of environmental factors, their interactions, and
interaction with genetic factors on children’s
health and development.
Application of uncertainty and safety
factors that speciﬁcally consider children’s risks.
Children must be presumed to be more vulner-
able to environmental toxic agents than adults
in the absence of data to the contrary, as was
specifically recommended by the NRC
Committee on Pesticides in the Diets of Infants
and Children (NAS 1993). That committee
called for the incorporation of an additional
child-protective uncertainty factor into risk
assessment to account for this greater vulnera-
bility, particularly in the absence of data, and
the FQPA mandated the application of an
additional margin of safety for children’s risk in
the case of pesticides (FQPA 1996). Traditional
approaches to risk assessment are now being
modified to more carefully and explicitly
account for risks to children (U.S. EPA 2002a).
However, a number of data gaps in exposure
assessment and in developmental toxicity must
be addressed through the development and
implementation of additional testing guideline
protocols (U.S. EPA 1999, 2002b), the acquisi-
tion of better information on children’s expo-
sure patterns and sources, and the undertaking
of basic research both on mechanisms of under-
lying development and on chemical inter-
actions of environmental agents with
developing organ systems (NRC 2000).
Conclusion
The protection of children against toxic chemi-
cals in the environment is a major challenge to
modern society (Schaefer 1994). Children are
not merely a special vulnerable group within
our population but rather the current inhabi-
tants of a developmental stage through which
all future generations must pass. Protection of
the health of fetuses, infants, and children is
essential for sustainability of the human species.
The current challenge to risk assessment
stems from two facts: a) hundreds of new
chemicals are developed every year, released in
varying quantities into the environment, and
absorbed into the bodies of many American
children (CDC 2003); and b) the majority of
these chemicals are not adequately evaluated
prior to commercial introduction for their
potential toxicity, their potential effects on
development, or their possible interactive
effects with other chemicals (Goldman 2000;
Landrigan and Goldman 2003; NAS 1984).
The need, in this context, is to design
approaches to risk assessment that account for
the unique exposures and sensitivities of chil-
dren and that also will stimulate enhanced
research in developmental toxicity. The ulti-
mate goal is to formulate policies that will pro-
tect children against potential toxic agents and
allow them to grow, develop, and reach matu-
rity without incurring neurobehavioral impair-
ment, immune dysfunction, reproductive
damage, or increased risks of cancer as a conse-
quence of environmental exposures in early life.
The protection of children against toxic
chemicals in the environment will require
fundamental and far-reaching revisions of
current approaches to surveillance, toxicity
testing, and risk assessment. No guidance
document on risk assessment that fails to con-
sider the unique exposures and special suscep-
tibilities of fetuses, infants and children can
today be considered adequate to protect
human health.
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